Section Arrow
CLDI.NYSE-M
- Calidi Biotherapeutics
Quotes are at least 15-min delayed:2025/05/31 19:54 EDT
Last
 0.3475
-0.0293 (-7.78%)
Day High 
0.3796 
Prev. Close
0.3768 
1-M High
0.509799 
Volume 
494.00K 
Bid
0.35
Ask
0.3533
Day Low
0.3401 
Open
0.37 
1-M Low
0.3666 
Market Cap 
11.98M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.41 
20-SMA 0.43 
50-SMA 0.5 
52-W High 3.89 
52-W Low 0.3401 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-1.12/-8.80
Enterprise Value
14.57M
Balance Sheet
Book Value Per Share
0.22
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.01
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
INABIN8bio0.1446-0.0088-5.74%-- 
BLRXBioLineRx Ltd5.18+1.3891+36.64%-- 
IMNNImunon2.45+0.46+23.12%-- 
NCNANuCana plc0.03525-0.00175-4.73%-- 
MRNAModerna26.58-0.35-1.30%-- 
Quotes are at least 15-min delayed:2025/05/31 19:54 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.